"10.1371_journal.pone.0111333","plos one","2014-10-30T00:00:00Z","Reem R Al Olaby; Laurence Cocquerel; Adam Zemla; Laure Saas; Jean Dubuisson; Jost Vielmetter; Joseph Marcotrigiano; Abdul Ghafoor Khan; Felipe Vences Catalan; Alexander L Perryman; Joel S Freundlich; Stefano Forli; Shoshana Levy; Rod Balhorn; Hassan M Azzazy","Department of Chemistry, The American University in Cairo, New Cairo, Egypt; Center for Infection and Immunity of Lille, CNRS-UMR8204/Inserm-U1019, Pasteur Institute of Lille, University of Lille North of France, Lille, France; Pathogen Bioinformatics, Lawrence Livermore National Laboratory, Livermore, CA, United States of America; Protein Expression Center, Beckman Institute, California Institute of Technology, Pasadena, CA, United States of America; Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, United States of America; Department of Medicine, Stanford University Medical Center, Stanford, CA, United States of America; Department of Medicine, Division of Infectious Diseases, Center for Emerging & Re-emerging Pathogens, Rutgers University-New Jersey Medical School, Newark, NJ, United States of America; Department of Pharmacology and Physiology, Rutgers University-New Jersey Medical School, Newark, NJ, United States of America; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States of America; Department of Applied Science, University of California Davis, Davis, CA, United States of America","Conceived and designed the experiments: RRA LC AZ JD JV JM JSF SF SL RB HMA. Performed the experiments: RRA AZ LS AGK FVC ALP SF. Analyzed the data: RRA LC AZ JV AGK FVC ALP SF RB. Contributed reagents/materials/analysis tools: RRA JD JV JM JSF SL HMA. Contributed to the writing of the manuscript: RRA LC AZ RB.","Reem Al Olaby, Dr. Hassan Azzazy and Dr. Rod Balhorn are co-inventors on a patent application related to the described work that has been submitted by The American University in Cairo, Cairo, Egypt. The title for the application is Ligands That Target Hepatitis C Virus E2 Protein. None of the other coauthors have competing interests. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","10","Reem R Al Olaby","RRAO",15,TRUE,11,7,9,NA,TRUE,TRUE,FALSE,0,NA,FALSE
